Intellia Therapeutics (NTLA) Q3 2024 Earnings

8AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-1.52
-1.39
-1.25
-1.12

Details

Expected EPS
-1.21681
Actual EPS
-1.52
Surprise EPS
-0.3
Surprise Percent
+24.92%

Description

Intellia Therapeutics (NTLA) has reported earnings of -1.52 per share for Q3 2024.

0 Comments

Share your thoughts